Background The economic burden of interstitial lung disease (ILD) is unknown, limiting
informed resource allocation and planning. We sought to conduct the first systematic review on …

… on the economic burden of asthma and COPD and to highlight some of the noticeable
variations and geographical and temporal trends in the economic burden of asthma and COPD. …

… Since the 1960s, beta-2 agonists are the mainstay of therapy for obstructive lung diseases
with studies demonstrating sustained improvement in peak flows and respiratory symptoms …

… only COPD. Because of the significant worldwide burden of disease and economic implications,
… , the Global initiative for chronic Obstructive Lung Disease (GOLD), were launched more …

… , carrying a notable economic burden. This systematic literature review aimed to highlight
the economic burden associated with moderate-to-very severe COPD and to investigate key …

… We aimed to review the prevalence and economic burden of … TB and post-TB lung disease,
they mainly included acute TB. … post-TB lung disease, the total clinical and economic burden …

… , namely interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH), is a
prominent feature of SSc, occurring more frequently in SSc than other connective tissue diseases, …

… Evidence about the economic burden related to interstitial lung diseases (ILDs) and the
cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the clinical …

… baseline characteristics by SAS in each disease cohort. We then stratified the analyses to
examine the effect of SAS on economic burden by disease cohort. Specifically, medical …

… and indirect costs of lung diseases. … COPD is highly prevalent and can be severely disabling,
medical expenditures for treating COPD can represent a substantial economic burden for …